National Health Insurance for South Africa: Towards Universal Health Coverage

Public Health National Health Strategy 2015
South Africa English PDF
National

AI-Generated Document Summary

Objectives

National Health Insurance (NHI) is South Africa’s route towards universal health coverage: a publicly financed, publicly administered system intended to provide all South Africans with access to quality, affordable personal health services according to need rather than socio-economic status. It treats health care as a public good and social investment, founded on social solidarity, equity, justice, affordability, efficiency and financial-risk protection.

  • Achieve universal population, service and cost coverage, progressively extending entitlement to South Africans and legal permanent residents while prioritising people facing the greatest barriers to care.
  • Provide comprehensive promotive, preventive, curative, rehabilitative and palliative services across community outreach, primary health care, hospital, specialised, pharmacy, laboratory and emergency medical services.
  • Protect households from direct payments, co-payments and catastrophic expenditure for covered services, while reducing fragmentation among public and private funding pools.
  • Address structural weaknesses including inequitable financing, uneven quality, a curative and hospital-centred system, maldistribution of health workers, inefficient purchasing and the high burden of communicable, non-communicable, maternal and child health conditions, and injury and trauma.
  • Improve health outcomes and equity, including the stated 2030 aspirations for life expectancy of at least 70 years, infant mortality below 20 per 1,000 live births, under-five mortality below 30 per 1,000 live births, reduced HIV infection among people under 20, and a lower burden of disease.
  • Strengthen primary health care as the health-system foundation, using prevention and health promotion alongside treatment, with referral to higher levels of care when clinically required.
  • Establish a single national NHI Fund as the single payer and strategic purchaser, pooling resources to enable income and risk cross-subsidisation, economies of scale, efficient procurement and more equitable access.

Implementation

NHI is designed for phased implementation over 14 years through concurrent health-system strengthening, service-delivery reform, establishment of the NHI Fund, beneficiary registration, provider accreditation and contracting, and mobilisation of mandatory prepayment revenue. The public sector remains the backbone of provision, supplemented by accredited private providers where needed, while the Fund separates purchasing from provision and buys services according to population health needs and quality standards.

  • Re-engineer primary health care through ward-based outreach teams, the Integrated School Health Programme, District Clinical Specialist Teams, contracted private practitioners, community medicine collection points and integrated district-level referral networks.
  • Organise care around primary health care as the entry point, supported by bi-directional referral and feedback systems linking district, regional, tertiary, central and specialised hospitals.
  • Register beneficiaries through designated public facilities and issue encrypted NHI cards linked to the Department of Home Affairs smart identification system, supported by the Health Patient Registration System, Master Patient Index and Health Provider Index.
  • Accredit providers against norms and standards certified by the Office of Health Standards Compliance, then contract public and private providers through agreements covering patient volumes, care quality, clinical protocols, reporting requirements and payment conditions.
  • Use strategic purchasing, pooled procurement and revised provider payments to replace passive line-item and fee-for-service arrangements. Primary care is intended to use risk-adjusted capitation with performance elements, while hospitals move towards activity-based global budgets and ultimately case-mix reimbursement.
  • Apply Standard Treatment Guidelines and the Essential Drug List, with evidence-based review of efficacy, safety, cost-effectiveness, epidemiological priorities and practical feasibility. Expert Committees and Clinical Peer Review Committees are intended to address guideline gaps and justified clinical exceptions.
  • Strengthen hospitals through increased managerial authority, cost centres, qualified management, Hospital Boards, central-hospital reform and national oversight, while using a transitional funding mechanism before the Fund is fully functional.
  • Improve quality through the Ideal Clinic model, continuous compliance with national standards, facility inspection, patient-satisfaction measurement, Ombud complaint investigation and corrective action.
  • Build workforce capacity through improved planning, equitable deployment, training expansion, rural retention measures, international collaboration and contractual engagement of private professionals.
  • Strengthen pharmaceutical, laboratory and emergency services through central procurement, medicine distribution systems, essential laboratory testing, demand-management rules, revised laboratory reimbursement, nationally standardised emergency medical services and accredited public-private contracting.
  • Govern the Fund as an autonomous national entity established through legislation, with dedicated functions for benefits design, pricing, accreditation, contracting, procurement, provider payment, performance monitoring, audit, risk management and fraud prevention.
  • Require routine provider information on diagnoses, procedures, medicines, tests, referrals, admissions and discharge, and use linked information systems to monitor utilisation, health outcomes, purchasing, quality, expenditure, fraud and epidemiological profiles.
  • Report Fund performance at least quarterly to the NHI Commission and annually to Parliament, including audited financial and non-financial performance, while using Commission oversight and civil-society representation to reinforce accountability.
  • Mobilise financing through mandatory prepayment and a unified pool, with illustrative tax scenarios involving payroll taxes, personal-income-tax surcharges and value-added-tax increases; the source presents these scenarios as illustrations rather than approved tax proposals.

Monitoring & Evaluation

Monitoring and accountability arrangements combine quality regulation, provider accreditation, routine information systems, performance management, financial oversight and policy review. The National Health Insurance (NHI) Fund is intended to use data on service use, outcomes, costs, diagnoses, treatment and referrals to support strategic purchasing, risk adjustment and contract management.

  • Monitor quality through the Office of Health Standards Compliance, which assesses establishments against seven national quality domains and six core standards, certifies compliant facilities and investigates complaints through its Ombud function.
  • Require providers to meet certification and accreditation requirements before contracting, comply with clinical protocols and treatment guidelines, submit patient-level information, and accept sanctions or contract review for non-compliance.
  • Measure contracted primary-care provider performance against agreed standards, progressively extending assessment towards public-health outcomes in defined catchment populations.
  • Use the Fund’s Performance Monitoring Unit to assess clinical indicators, health outcomes and clinical governance, rather than perceived quality alone.
  • Report at least quarterly to the NHI Commission and annually to Parliament, with an annual published report covering audited financial and non-financial performance.
  • Maintain demographic and epidemiological databases, conduct health-economic and actuarial analysis, and undertake ongoing research, monitoring and evaluation of NHI effects on health outcomes.
  • Use interoperable patient and provider registration systems to track coverage, visits, utilisation, referrals, service delivery and disease profiles, while supporting management reporting and research.
  • Manage fraud, waste and inappropriate expenditure through integrated data systems, risk registers, data-mining, clinical pathways, process-mining and governance oversight.
  • Review benefits, treatment guidelines and the national health-products list using evidence on efficacy, cost-effectiveness, technology assessment, disease burden, utilisation and product prices.

Specified outcome and implementation measures include 2030 targets for life expectancy, infant and under-five mortality, HIV among people under 20, universal coverage, equity, efficiency and quality.Pilot monitoring recorded household profiling, school-health contacts and referrals, vaccination coverage, District Clinical Specialist Team staffing, contracted general-practitioner activity and patient volumes.However, many extracts do not define a consolidated national indicator set, indicator methodology, reporting timetable, surveillance system or independent evaluation process.

Costing & Financing

NHI financing is designed around a single public pool, mandatory prepayment, cross-subsidisation according to ability to pay and health need, strategic purchasing, and services free at the point of care for entitled users.Cost containment relies on pooled procurement, provider-payment reform, clinical guidelines, benefits prioritisation, global budgets, capitation, case-mix payment and controls on unnecessary services.

  • Project NHI expenditure at 134,324 million South African rand in 2015/16, 185,370 million in 2020/21 and 255,815 million in 2025/26, in 2010 prices.
  • Estimate a 2025/26 financing shortfall of 108,080 million South African rand with 2.0% annual baseline-resource growth, 71,914 million with 3.5% growth, and 27,613 million with 5.0% growth.
  • Assume 3.5% annual economic growth in the central projection, under which public health expenditure rises from around 4% to 6.2% of gross domestic product by 2025/26.
  • Illustrate tax options that could raise 71.9 billion South African rand, in 2010 prices, by 2025/26 through varying combinations of payroll tax, income-tax surcharges and value-added-tax increases.
  • Use existing public expenditure, medical-scheme subsidies and tax credits, compensation-fund health benefits, conditional grants, equitable-share allocations and other grants as potential transitional or reallocated funding sources.
  • Recognise that projections are illustrative rather than expenditure commitments and depend on economic growth, demand, utilisation, absorptive capacity, workforce and facility capacity, provider mix, reimbursement choices, technology, population ageing and confidence in public services.

In 2013/14, total health expenditure was estimated at 310,536 million South African rand, including 148,994 million in the public sector, 155,689 million in the private sector and 5,852 million from donors or non-governmental organisations.The financing context is marked by fragmented pools, high private expenditure, direct household payments and uneven benefit distribution.Private medical-scheme expenditure was estimated at 139.1 billion South African rand in 2014/15, alongside an estimated 20 billion state employee subsidy and 16 billion in tax credits.

Other revenue sources considered include general, payroll and consumption taxes, duties on alcohol and tobacco, securities transfer tax, estate duty and possible carbon-tax receipts, although smaller or volatile sources are not presented as a sufficient main basis for long-term financing.The extracts do not provide approved NHI budgets, binding allocations, final tax rates or a definitive resource-mobilisation plan.

Document Viewer